Cite
MLA Citation
J. Anton et al.. “THU0490 Canakinumab Treatment of Patients with Hyper-IgD Syndrome: An Open-Label, Multicenter, Pilot Study.” Annals of the rheumatic diseases, vol. 72, 2013, pp. A329–A330. http://access.bl.uk/ark:/81055/vdc_100137793158.0x000057